News

Texas Instruments beat expectations and raised guidance, signalling robust demand across two major growth drivers: industrial manufacturing and data-centre infrastructure. This is a positive signal for the semiconductor sector's health beyond just AI euphoria, suggesting genuine underlying demand from manufacturers and enterprise capex. For Australian investors, this supports ASX tech stocks and exposure to semiconductor supply chains, though TXN's strength also reflects broader US industrial resilience—watch whether this momentum extends to local engineering and industrial stocks in coming earnings.

IBM's software revenue disappointed the market, adding to broader investor concerns about how artificial intelligence adoption might cannibalize traditional software and consulting revenue streams. This matters because IBM is a bellwether for enterprise tech spending—if legacy IT services are under pressure from AI disruption, it could signal margin compression across the sector. Australian investors should monitor whether this weakness spreads to other established tech names on the ASX and watch for similar guidance misses from local software and consulting firms in coming earnings seasons.

ServiceNow delivered Q1 revenue of $3.77B, meeting expectations, with non-GAAP EPS of $0.97 in line with consensus. The company maintains its position as a leading enterprise cloud software provider, though an in-line beat suggests steady rather than exceptional performance. Australian investors exposed to US software stocks should monitor ServiceNow's forward guidance and whether the company's AI-driven growth initiatives are translating into margin expansion—particularly relevant given the sector's valuation multiples remain compressed post-rate-hike cycle.

Tesla beat earnings expectations with 41 cents per share but missed on revenue, signalling mixed performance as Musk shifts focus toward AI, robotics, and autonomous vehicles. The stock got a modest lift from the earnings beat, though the company faces headwinds from Chinese EV competition and demand concerns in key markets. For Australian investors, Tesla's strategic pivot away from traditional car sales toward software and robotics could redefine its valuation multiple over coming quarters—watch whether management can deliver on AI/robotaxi promises or if the core auto business deteriorates further.

Texas Instruments reported Q1 revenue of $4.83B, up 19% year-on-year, driven by strong demand from data centre customers capitalising on the AI infrastructure buildout. This signals robust underlying demand in the semiconductor sector despite broader economic headwinds, though TXN's analogue/embedded focus makes it less directly exposed to leading-edge AI chips than pure-play fabless designers. Australian tech investors should watch for this as a health check on global semiconductor demand—strength here typically flows through to ASX-listed peers like Wisetech Global and can influence the broader ASX200 Tech index.

Tesla delivered earnings and revenue results that exceeded analyst expectations in Q1, signalling continued operational strength despite broader EV market headwinds and competitive pressure. This beat is relevant for Australian investors as Tesla is a major US tech holding in many local portfolios and a barometer for EV industry health. Watch for management commentary on margins, global production capacity, and pricing strategy in the earnings call, as these will indicate whether Tesla can sustain profitability amid rising competition and potential economic slowdown.

Google is committing up to $185 billion this year on AI infrastructure, signalling aggressive capital deployment to maintain leadership in autonomous AI agents—a technology race shaping the next computing era. This massive capex increase reflects confidence in AI monetisation but also competitive pressure from rivals like OpenAI and Microsoft, and will pressure near-term profitability while driving long-term growth in cloud and semiconductor demand. Australian investors should note this boosts demand for data centre components and broadens exposure to the AI infrastructure buildout, though Alphabet's CapEx intensity will be a key earnings metric to watch.

Blackstone's Q1 results highlight resilience in real estate and growing momentum in private credit—two key pillars of the alternative asset management industry. Strong real estate performance reflects sustained investor appetite despite higher interest rates, while private credit expansion signals ongoing shift away from traditional banking. For Australian investors, this matters because it shows institutional capital is flowing into alternatives; ASX-listed asset managers and property trusts may benefit from similar tailwinds, though it also indicates competition for yield in a higher-rate environment.

Intel's Q1 earnings will hinge on server CPU demand, which remains a bright spot amid broader semiconductor challenges. However, the company faces persistent headwinds from its struggling foundry business and margin compression—issues that have weighed on the stock and investor confidence. For Australian tech investors, Intel's performance signals the health of global data centre spending and chip manufacturing competitiveness, particularly relevant as the ASX tech sector tracks US semiconductor trends and as Australia develops its own chip strategy.

EQT, a Swedish private equity firm, has raised its takeover bid for Intertek, a UK-listed testing, inspection and certification company. This improved offer suggests the deal is progressing and increases the likelihood of a successful acquisition, which would be positive for Intertek shareholders. Australian investors with exposure to Intertek or similar professional services stocks should monitor the deal's progress, as consolidation in this sector can signal strong underlying demand for quality assurance and compliance services globally.

Boeing's defence division is offsetting weakness in its commercial aircraft business, with strong revenue growth driven by a U.S. government contract for PAC-3 missiles and apparent political tailwinds. While this provides near-term earnings support for Boeing, the underlying commercial aircraft challenges—particularly the 737 MAX and 777X programs—remain unresolved. For Australian investors, this matters less directly but signals U.S. defence spending momentum, which could support allied defence contractors on the ASX like Northrop Grumman suppliers and indirectly benefit Australian defence primes.

Boeing reported better-than-expected Q1 earnings and reached a record $695 billion order backlog, signalling strong long-term demand for commercial aircraft as the industry recovers post-pandemic. This is positive for Boeing's revenue visibility, though execution risks remain given the company's recent quality control issues and regulatory scrutiny. Australian investors with exposure to aerospace suppliers or defence contractors should note the strengthening demand cycle, though Boeing's valuation and near-term cash flow challenges from production ramp-up remain key watch points.

Philip Morris International beat Q1 earnings expectations with revenue growth of 9.1%, supported by strength across both smoke-free products (like IQOS) and traditional combustibles. This signals the company's diversification strategy is gaining traction as it pivots away from conventional cigarettes toward reduced-risk products. For Australian investors, this matters because PM is a major global consumer staple held in many portfolios; the earnings beat supports valuations of large-cap multinational tobacco plays, though ongoing regulatory headwinds in developed markets remain a longer-term concern.

AT&T's earnings reveal success in its fiber-to-the-home expansion, with bundled internet and wireless packages driving customer growth and potentially improving margins. The bundling strategy is meaningful because it increases customer stickiness and lifetime value—a structural shift in how telcos compete beyond just pricing. Australian investors should note the parallel with NBN rollout completion here; telcos globally are discovering fibre bundling works well, which has implications for Telstra and Optus' own bundling strategies and competitive positioning.

Otis Worldwide beat revenue expectations in Q1 but disappointed on adjusted earnings per share, a mixed signal for the elevator and escalator manufacturer. The company partially offset the EPS miss by raising full-year 2026 revenue guidance, suggesting confidence in underlying demand despite margin pressures. For Australian investors, Otis is a global industrial play with exposure to construction and real estate cycles—the guidance lift is constructive, but the EPS miss signals cost or pricing headwinds worth monitoring in coming quarters.

Capital One's 72% surge in bad-debt provisions signals deteriorating credit quality and growing concern about loan defaults, likely driven by consumer stress from higher interest rates and inflation. The earnings miss compounds the concern, suggesting profitability is being squeezed by both higher credit costs and loan losses. Australian investors should monitor this as a canary for global financial stress—similar trends at Australian banks like CBA and Westpac would be concerning for dividend yields and sector valuations on the ASX.

Cochlear experienced a significant sell-off that triggered a broader healthcare sector decline on the ASX, with banking stocks also coming under pressure on the day. This type of contagion effect suggests either company-specific bad news (likely earnings or guidance miss) that spooked healthcare investors more broadly, or concerns about sector fundamentals. Australian investors should monitor whether this reflects genuine healthcare sector weakness or if it's isolated to Cochlear—the spillover pattern will indicate market confidence in other healthcare names like ResMed and other medical device players.

Cochlear delivered a major earnings miss that triggered a near-40% share price collapse—its worst single day in three decades. This signals serious operational or demand headwinds for the world-leading hearing implant maker, likely driven by either product/market challenges or margin compression. Australian investors should monitor whether this reflects broader healthcare sector weakness or is company-specific; given Cochlear's ASX200 weight and export-heavy business model, broader market ripple effects are possible.

Brazilian Critical Minerals has increased the mineral resource estimate (MRE) for its Ema project by 58%, a significant expansion that strengthens the company's reserve base and de-risks future development. This is positive for BCM shareholders and relevant to Australian investors given the ASX listing and growing importance of critical minerals supply chains—particularly for rare earths and battery materials. Watch for updates on project financing, permitting timelines, and commodity price movements (rare earths, lithium) that will determine whether this resource expansion translates to production and cash flow.

Cochlear, a flagship ASX-listed medical device maker, has issued a significant profit downgrade, triggering a 40% share price collapse to a 10-year low and dragging the broader ASX down with it. This signals weakness in a major Australian bellwether stock and likely reflects softer demand in key markets or operational headwinds in the hearing implant sector. For ASX investors, this is a reminder that even quality large-cap exporters face cyclical pressures; watch for sector-wide guidance revisions and whether this weakness spreads to other healthcare and industrial exporters.